317
Participants
Start Date
October 31, 2010
Primary Completion Date
November 30, 2011
Study Completion Date
November 30, 2011
Vildagliptin
Placebo
Novartis Investigative Site, Box Hill
Novartis Investigative Site, Heidelberg
Novartis Investigative Site, Parkville
Novartis Investigative Site, St Leonards
Novartis Investigative Site, Anderbeck
Novartis Investigative Site #1, Berlin
Novartis Investigative Site #2, Berlin
Novartis Investigative Site #3, Berlin
Novartis Investigative Site #4, Berlin
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Hildesheim
Novartis Investigative Site, Sangerhausen
Novartis Investigative Site, Budapest
Novartis Investigative Site, Érd
Novartis Investigative Site, Törökbálint
Novartis Investigative Site, Bergamo
Novartis Investigative Site, Cosenza
Novartis Investigative Site, Milan
Novartis Investigative Site, Padua
Novartis Investigative Site, Pisa
Novartis Investigative Site #1, Roma
Novartis Investigative Site #2, Roma
Novartis Investigative Site, Torino
Novartis Investigative Site #1, Aguascalientes
Novartis Investigative Site #2, Aguascalientes
Novartis Investigative Site #3, Aguascalientes
Novartis Investigative Site #1, Durango
Novartis Investigative Site #2, Durango
Novartis Investigative Site #3, Durango
Novartis Investigative Site #1, Guadalajara
Novartis Investigative Site #2, Guadalajara
Novartis Investigative Site #3, Guadalajara
Novartis Investigative Site #4, Guadalajara
Novartis Investigative Site #5, Guadalajara
Novartis Investigative Site, México
Novartis Investigative Site #1, Pachuca
Novartis Investigative Site #2, Pachuca
Novartis Investigative Site #3, Pachuca
Novartis Investigative Site, Manila
Novartis Investigative Site #1, Quezon City
Novartis Investigative Site #2, Quezon City
Novartis Investigative Site, Alba Iulia
Novartis Investigative Site, Bucharest
Novartis Investigative Site #1, Oradea
Novartis Investigative Site #2, Oradea
Novartis Investigative Site, Târgu Mureş
Novartis Investigative Site, Bundang
Novartis Investigative Site #1, Seoul
Novartis Investigative Site #2, Seoul
Novartis Investigative Site #3, Seoul
Novartis Investigative Site, Suwon
Novartis Investigative Site, Changhua
Novartis Investigative Site, Taichung
Novartis Investigative Site, Taipei
Novartis Investigative Site, Yongkang District
Lead Sponsor
Novartis
INDUSTRY